Citadel Advisors LLC bought a new position in shares of Phibro Animal Health Corp (NASDAQ:PAHC) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 8,745 shares of the company’s stock, valued at approximately $293,000.

Other hedge funds also recently made changes to their positions in the company. First Manhattan Co. acquired a new position in Phibro Animal Health in the fourth quarter valued at approximately $100,000. Dean Capital Investments Management LLC acquired a new position in Phibro Animal Health in the fourth quarter valued at approximately $200,000. Teacher Retirement System of Texas acquired a new position in Phibro Animal Health in the fourth quarter valued at approximately $224,000. Municipal Employees Retirement System of Michigan lifted its holdings in Phibro Animal Health by 65.9% in the third quarter. Municipal Employees Retirement System of Michigan now owns 7,250 shares of the company’s stock valued at $269,000 after buying an additional 2,880 shares during the period. Finally, Crossmark Global Holdings Inc. acquired a new position in Phibro Animal Health in the fourth quarter valued at approximately $253,000. Institutional investors own 48.09% of the company’s stock.

How to Become a New Pot Stock Millionaire

Shares of Phibro Animal Health Corp (NASDAQ:PAHC) opened at $40.25 on Wednesday. Phibro Animal Health Corp has a 12 month low of $26.70 and a 12 month high of $41.05. The company has a quick ratio of 1.75, a current ratio of 3.12 and a debt-to-equity ratio of 1.82. The company has a market cap of $1,597.59, a P/E ratio of 26.31, a price-to-earnings-growth ratio of 2.82 and a beta of 0.97.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Monday, February 5th. The company reported $0.44 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.38 by $0.06. Phibro Animal Health had a net margin of 7.90% and a return on equity of 40.49%. The firm had revenue of $205.90 million during the quarter, compared to the consensus estimate of $194.90 million. During the same quarter in the prior year, the firm earned $0.39 earnings per share. The business’s quarterly revenue was up 7.5% on a year-over-year basis. equities research analysts forecast that Phibro Animal Health Corp will post 1.69 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 28th. Shareholders of record on Wednesday, March 7th will be paid a $0.10 dividend. This represents a $0.40 annualized dividend and a yield of 0.99%. The ex-dividend date of this dividend is Tuesday, March 6th. Phibro Animal Health’s payout ratio is presently 26.14%.

In other news, COO Larry Lee Miller sold 54,572 shares of the stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $35.36, for a total transaction of $1,929,665.92. Following the completion of the sale, the chief operating officer now owns 8,582 shares of the company’s stock, valued at $303,459.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Dean J. Warras sold 10,000 shares of the stock in a transaction on Friday, February 9th. The stock was sold at an average price of $35.62, for a total transaction of $356,200.00. Following the sale, the insider now directly owns 10,000 shares of the company’s stock, valued at approximately $356,200. The disclosure for this sale can be found here. Insiders sold 240,056 shares of company stock valued at $9,052,620 in the last ninety days. Insiders own 51.88% of the company’s stock.

Several brokerages have commented on PAHC. BidaskClub raised shares of Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research note on Saturday, January 6th. ValuEngine raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Wednesday, February 28th. Credit Suisse Group upped their target price on shares of Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a research note on Tuesday, February 6th. Zacks Investment Research raised shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Monday, January 8th. Finally, Morgan Stanley upped their target price on shares of Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a research note on Wednesday, February 7th. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $38.20.

ILLEGAL ACTIVITY NOTICE: This story was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The legal version of this story can be viewed at https://www.dailypolitical.com/2018/03/14/citadel-advisors-llc-invests-293000-in-phibro-animal-health-corp-pahc.html.

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.